Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Med Virol1
Search Results
Sort by
- BookWilliam F. Armstrong, Thomas Ryan.Summary: "Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Continuing the long-standing Feigenbaum tradition as an authoritative, comprehensive echocardiography resource, the thoroughly revised Feigenbaum's Echocardiography, Eighth Edition, helps echocardiographers, fellows, clinicians, and sonographers master the art and science of echocardiography and stay current with all that's new in the field. Written by William F. Armstrong and Thomas Ryan, it guides you through pertinent physics, technology, clinical applications, and new developments in the field. As in the past, the book is written primarily for the practitioner who uses echocardiographic methods to care for and manage patients, with a focus on appropriate clinical applications.Features enhanced online content including echo clips, case studies, and more.Includes new content specifically for cardiac sonographers. Reflects new training guidelines for cardiology fellows emphasizing the importance of echocardiography in the general practice of cardiology.Describes the interrelationship of other imaging technologies with echocardiography and the role of echo as part of a multimodality approach to patients. Contains more than 1,600 high-quality illustrations - 600 in full color.Covers the use of 3D echocardiography and perfusion imaging; current AHA/ACC guidelines, appropriate use guidelines, and the mechanics and utility of strain and strain rate imaging.Enrich Your eBook Reading Experience with Enhanced Video, Audio and Interactive Capabilities! Read directly on your preferred device(s), such as computer, tablet, or smartphone Customize for your language</B>, including right-to-left reading, vertical writing, and enhanced annotation in over 30 languages Easily convert to audiobook, powering your content with natural language text-to-speech Adapt for unique reading needs, supporting learning disabilities, visual/auditory impairments, second-language or literacy challenges, and more"--Provided by publisher.
Contents:
History
Physics
Contrast
Normal exam
Systolic Function
Diastole
LA, RA, RV
Hemodynamics
Pericardial
Aortic valve
Mitral valve
TV and PV
IE
Pros valves
CAD
Stress echo
Dilated CM
HCM and other CM
CHD
Aorta
ICU and Periop
Systemic diseases
Masses, tumors, and source of embolus. - ArticleMiller LW, Togo Y, Hornick RB.J Med Virol. 1977;1(3):193-9.The clinical effects, nasal and serum antibody responses, and virus excretion of a live attenuated serum inhibitor-resistant influenza B virus vaccine, R75, was evaluated in 43 seronegative healthy adults by a random double-blind study. Symptom responses were minimal and were not significantly different between vaccine and placebo groups. No fevers, abnormalities in physical examination or laboratory testing developed during 4 weeks of observation. Among vaccinees, 10 (48%) developed serum hemagglutination-inhibition (HI) antibodies, 16 (76%) developed serum neutralization (N) antibodies and 4 (19%) developed nasal N antibodies. The GMT responses from study day 0 to day 28 were 4.0 to 10.4 for serum HI, 1.8 to 9.8 for serum N, and 1.0 to 1.4 for nasal N. There were no significant titer changes in the placebo group. No virus excretion was detected. Although there are some questions concerning the relationship of antibody levels to protection, the low antibody responses in this study are an indication that R75 is not sufficiently immunogenic.